Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

A molecular blueprint for targeting cancer?

Nature Genetics volume 21, pages 64–65 (1999)Cite this article

Wouldn't it be fabulous if inspection of a tumour would immediately suggest the most effective therapy for total eradication of the disease? The ability to rapidly translate the defects of a tumour cell into a molecular blueprint for therapeutic targeting is an important step in the realization of this dream. To this end, researchers have charted every conceivable quality of tumour cells—including biochemical peculiarities and genetic abnormalities—with the hope of identifying signature changes that indicate the critical defects of a given tumour's physiology. Armed with this accumulated knowledge, we may soon be able to customize therapy. For this approach to be effective, we need techniques that can rapidly scan the total genome for mutations, and an understanding of the functional significance of the mutational spectra. On page 99 of this issue, Laleh Shayesteh and colleagues provide a nascent example of the latter; they present data suggesting that PIK3CA, encoding PI3–kinase, is an oncogene important in ovarian cancer by virtue of its frequent amplification in these tumours.

For defined phenotypes such as drug resistance, identification of the amplified gene is straightforward because manipulation of the candidate gene may verify or refute its effect. Furthermore, the selection pressure—in this case, growth in the presence of drug—is defined. For more complex phenotypes, such as tumorigenic potential, the complexity of the variables involved in generating the phenotype renders analysis immensely more difficult. For this reason, most genes that respond to selection pressure and drive the plethora of amplifications and deletions identified by chromosomal analysis of tumour samples are currently unknown.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Karyotypic abnormalities associated with gene amplification.
Figure 2: Recruitment and activation of PI3–kinase.

References

  1. Biedler, J.L. & Spengler, B.A. Science 191, 185–187 (1976).

    Article  CAS  Google Scholar 

  2. Alt, F.W. et al. J. Biol. Chem. 253, 1357.

  3. Franke, T.F. et. al. Science 275, 665– 668 (1997).

    Article  CAS  Google Scholar 

  4. Marte, B.M. & Downward J. TIBS 22, 355–358 (1997).

    CAS  PubMed  Google Scholar 

  5. Khwaja, A. et al. EMBO J. 16, 2783–2793 (1997).

    Article  CAS  Google Scholar 

  6. Kulik, G. et. al. Mol. Cell. Biol. 17, 1595– 1606 (1997).

    Article  CAS  Google Scholar 

  7. Hemmings, B.A. Science 275, 628–630 ( 1997).

    Article  CAS  Google Scholar 

  8. Stambolic, V. et. al. Cell 95, 29–39 (1998).

    Article  CAS  Google Scholar 

  9. Myers, M.P. et. al. Proc. Natl Acad. Sci. 95, 13513– 13518 (1998).

    Article  CAS  Google Scholar 

  10. Haber, D.A. & Schimke, R.T. Cell 26, 355–362 (1981).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and UCSF Cancer Center, University of California, San Francisco, 94143-0506 , California, USA

    Thea D. Tlsty

Authors
  1. Thea D. Tlsty
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tlsty, T. A molecular blueprint for targeting cancer?. Nat Genet 21, 64–65 (1999). https://doi.org/10.1038/4998

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/4998

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing